A SECOND attempt to commercialise dental disease detection technology developed by Scottish universities has been dealt a blow after 3D Diagnostic Imaging unveiled a huge cost-cutting exercise and said it planned to delist from the Alternative Investment Market.
Shares in 3D Diagnostic Imaging plunged 53.8%, closing at 0.15p, compared to their listing price of 6p in November 2010.
The core of 3D Diagnostic had been on AIM before as IDMoS, a company that collapsed into administration in 2008. 3D is now valued at just £361,000.
Please enable cookies in your browser to display the rest of this article.